Covid-19 Resource Center
During these turbulent times, finding information is hard. The Quadax Resource Center will help keep you up to date on the latest COVID-19 topics, including laboratory testing, supply needs and payor and billing changes affecting reimbursement.
COVID-19 Payer Updates
Quadax is dedicated to keeping our clients up-to-date on the billing, reporting, and procedural information specific to each payer as it pertains to COVID-19.
Recent Blog Posts
Examine COVID Claims to Find RCM Weaknesses in Your Lab
As the virus continues to spread and testing volumes increase, high claim volumes can exacerbate existing billing issues. Studying COVID denials and payments can help you recognize operational inefficiencies that are hurting revenue.
COVID-19 Articles, Bulletins, Town Halls, Webinars
Date | Article | Source |
1/8/2021 | FDA Issues Alert Regarding SARS-CoV-2 Viral Mutation to Health Care Providers and Clinical Laboratory Staff | |
1/8/2021 | Coronavirus (COVID-19) Update: January 8, 2021 | |
1/4/2021 | New ICD-10-CM code for the | |
12/22/2020 | Coronavirus (COVID-19) Update: December 22, 2020 | |
12/19/2020 | CMS Updates FAQs for CLIA Guidance during the COVID-19 Public Health Emergency | |
12/15/2020 | FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine | |
12/15/2020 | FDA Authorizes Antigen Test as First Over-the-Counter Fully At-Home Diagnostic Test for COVID-19 | |
12/11/2020 | COVID-19 and in vitro diagnostics: New market forces at play | |
12/10/2020 | CMS offers guidance in billing Medicare for COVID-19 antibody treatment | |
12/10/2020 | FAQs–Application of OIG's Administrative Enforcement Authorities to Arrangements Directly Connected to the Coronavirus Disease 2019 (COVID-19) Public Health Emergency | |
12/7/2020 | Lab Advisory: CMS Revises Enforcement Discretion for SARS-CoV-2 Point-of-Care Tests | |
12/5/2020 | Lab Update: CDC Updates SARS-CoV-2 Antigen Testing Guidance | |
12/3/2020 | Lab Update: CDC Offers New COVID-19 Specimen Collection Infographics | |
12/4/2020 | 13 insurers extending COVID-19 cost-sharing waivers into 2021 | |
12/3/2020 | COVID-19 Frequently Asked Questions (FAQs) on Medicare Fee-for-Service (FFS) Billing | |
12/1/2020 | Job Aids for Laboratory Professionals | |
12/1/2020 | Clinical Laboratory COVID-19 Response Calls | |
11/24/2020 | Guidance for SARS-CoV-2 Point-of-Care Testing | |
11/24/2020 | Pathologists Advocate for Higher COVID-19 Payments During AMA Meeting | |
11/24/2020 | A Closer Look at COVID-19 Diagnostic Testing | |
11/23/2020 | 2020 Clinical Lab & Pathology Resources | |
11/19/2020 | HHS Launches Pilot Program of Fast Molecular POC Test for COVID-19 | |
11/18/2020 | Virtual Town Hall Series - Coronavirus (COVID-19) Test Development and Validation | |
11/18/2020 | The FDA issued an EUA for the first COVID-19 diagnostic test for self-testing at home that provides rapid results | |
11/18/2020 | The FDA published a new "FDA Insight" podcast titled: "Personal Protective Equipment and COVID-19" | |
11/17/2020 | CAP Members Call on Congress to Stop Medicare Cuts | |
11/17/2020 | CAP Asks CMS to Reduce COVID-19 Laboratory Reporting Burdens, Increase Testing Resources | |
11/11/2020 | CMS Details Medicare Payment for New COVID-19 Antibody Drug | |
11/10/2020 | AMA Announces Vaccine-Specific CPT Codes for COVID-19 Immunizations | |
11/9/2020 | The FDA issued an emergency use authorization (EUA) for the investigational monoclonal antibody therapy bamlanivimab for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients | |
11/2/2020 | Clinical Laboratories Need Creative Staffing Strategies to Keep and Attract Hard-to-Find Medical Technologists, as Demand for COVID-19 Testing Increases |
